Erratum: First-in-class pyrido[2,3-d]pyrimidine-2,4(1H,3H)-diones against leishmaniasis and tuberculosis: Rationale, in vitro, ex vivo studies and mechanistic insights
Arch Pharm (Weinheim)
.
2022 Apr;355(4):e2270007.
doi: 10.1002/ardp.202270007.
Epub 2022 Mar 1.
Authors
Deepthi Ramesh
,
Deblina Sarkar
,
Annu Joji
,
Monica Singh
,
Amaresh K Mohanty
,
Balaji G Vijayakumar
,
Mitali Chatterjee
,
Dharmarajan Sriram
,
Suresh K Muthuvel
,
Tharanikkarasu Kannan
PMID:
35229349
DOI:
10.1002/ardp.202270007
No abstract available
Publication types
Published Erratum